Home
About
Overview
Sharing Data
ORCID
Help
History (3)
Randomized phase II Study of carboplatin and etoposide with or without the bcl-2 antisense oligonucleotide oblimersen for extensive-stage small-cell lung cancer: CALGB 30103.
The next targets for small cell lung cancer.
Three-dimensional architecture of membrane-embedded MscS in the closed conformation.
See All 3 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
The next targets for small cell lung cancer.
The next targets for small cell lung cancer. Clin Adv Hematol Oncol. 2022 01; 20(1):35-36.
View in:
PubMed
subject areas
Carcinoma, Non-Small-Cell Lung
High-Throughput Nucleotide Sequencing
Humans
Lung Neoplasms
Small Cell Lung Carcinoma
authors with profiles
Ravi Salgia